Cargando…
Quantitation of chemosensitivity in acute myelocytic leukaemia.
A system for the prediction of clinical response in acute myelocytic leukaemia (AML), based on inhibition of growth of colony forming cells (CFC) was studied. If the product of initial drug concentration and time of exposure (C X T) was constant, the response to adriamycin (Adr) was constant, at T v...
Autores principales: | Lihou, M. G., Smith, P. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011489/ https://www.ncbi.nlm.nih.gov/pubmed/6578837 |
Ejemplares similares
-
Acute Myelocytic Leukæmia
por: Elder, William, et al.
Publicado: (1904) -
A Case of Myelocytic Leukæmia with Complications
por: McCay, F., et al.
Publicado: (1935) -
Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
por: Heuser, M, et al.
Publicado: (1998) -
In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
por: Larsson, R., et al.
Publicado: (1993) -
Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
por: Richel, D. J., et al.
Publicado: (1988)